This data is of great significance as several studies have consistently demonstrated that advanced NSCLC patients who are current smokers and exhibit positive PD‐L1 expression are more inclined to respond favorably to anti‐PD‐1 monotherapy in comparison to individuals who have never smoked.44, 45, 46, 47. Here, CD274 is linked to non-small cell lung carcinoma.